Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $113.43 USD
Change Today 0.00 / 0.00%
Volume 0.0
LH On Other Exchanges
New York
As of 8:04 PM 10/5/15 All times are local (Market data is delayed by at least 15 minutes).

laboratory crp of amer hldgs (LH) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/31/15 - $131.19
52 Week Low
10/15/14 - $95.61
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

laboratory crp of amer hldgs (LH) Related Businessweek News

No Related Businessweek News Found

laboratory crp of amer hldgs (LH) Details

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases. It also provides specialty testing services in the areas of allergy, clinical trials, diagnostic genetics, women's health, cardiovascular disease, identity, forensics, infectious disease, endocrinology, oncology, coagulation, occupational testing, and pain management. In addition, the company offers a range of early-stage and late-stage drug development services to the pharmaceutical and biotechnology industries, as well as laboratory testing services to the chemical, agrochemical, and food industries. Further, it operates an esoteric laboratory focused on personalized diagnostics for cardiovascular and metabolic disorders; and provides specialized forensic DNA analysis, proprietary DNA collection products, and relationship testing. The company provides its testing services through a sales force to the physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. Laboratory Corporation of America Holdings has collaboration with university, hospital and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

36,000 Employees
Last Reported Date: 02/26/15
Founded in 1971

laboratory crp of amer hldgs (LH) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $338.5K
Executive Vice President and Chief Executive ...
Total Annual Compensation: $632.6K
Chief Legal Officer, Chief Compliance Officer...
Total Annual Compensation: $436.1K
Senior Vice President and Chief Medical Offic...
Total Annual Compensation: $352.2K
Compensation as of Fiscal Year 2014.

laboratory crp of amer hldgs (LH) Key Developments

LabCorp Launches New FDA-Approved Lung Cancer Companion Diagnostic

Laboratory Corp. of America launched a new companion diagnostic assay developed by Agilent Technologies (A) that assesses whether non-small cell lung cancer patients are eligible for treatment with pembrolizumab (Keytruda). The PD-L1 IHC assay was approved by the Food and Drug Administration.

Laboratory Corporation of America Enters into Service Agreement in Support of Innovative Programs Dedicated to Processing Sexual Assault Kits Nationwide

Laboratory Corporation of America Holdings announced that Bode Cellmark Forensics, a member of the LabCorp Specialty Testing Group, has entered into an agreement with the New York County District Attorney's Office (DANY) that recognizes Bode Cellmark as a preferred forensic laboratory eligible to process untested sexual assault kits for grant recipients of DANY's Sexual Assault Kit Backlog Elimination Program. Grant recipients are now able to contract directly with Bode Cellmark for forensic DNA testing services. In addition, Bode Cellmark is eligible to perform testing for the U.S. Department of Justice's Bureau of Justice Assistance (BJA) Sexual Assault Kit Initiative, which recently awarded additional grants to address the nations sexual assault kit backlog.

Laboratory Corporation of America Holdings Expands Partnership with Perinatal Quality Foundation to Educate Patients and Healthcare Providers About Noninvasive Prenatal Testing

Laboratory Corporation of America Holdings announced an expansion of its long-standing partnership with the Perinatal Quality Foundation (PQF) to collaborate on a new strategic initiative focused on noninvasive prenatal screening, the Genetic Education Module (GEM). PQF’s GEM initiative will provide education to help patients and healthcare providers better understand the benefits and limitations of noninvasive prenatal screening and how to interpret the results of that screening. GEM will also build a patient registry designed to correlate the results of noninvasive prenatal testing with the results of confirmatory diagnostic tests, such as chorionic villus sampling (CVS) or amniocentesis, as well as post-partum outcomes. In addition, the initiative will help develop processes for credentialing healthcare personnel in the delivery of pre- and post- screening information. LabCorp and PQF are committed to improve patient outcomes and lives, while lowering costs, through expanded access to emerging healthcare technologies, such as their existing work on PQF’s Nuchal Translucency Quality Review program, which provides education and credentialing for sonographers and physicians involved in first trimester risk assessment.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $113.43 USD 0.00

LH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $62.12 USD 0.00
Hologic Inc $38.78 USD 0.00
PAREXEL International Corp $61.19 USD 0.00
Quest Diagnostics Inc $63.66 USD 0.00
Sonic Healthcare Ltd A$18.09 AUD -0.12
View Industry Companies

Industry Analysis


Industry Average

Valuation LH Industry Range
Price/Earnings 24.3x
Price/Sales 1.6x
Price/Book 2.4x
Price/Cash Flow 21.1x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at